Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.

Date publication

décembre 2022

Journal

Infection prevention in practice

Auteurs

Membres identifiés du Cancéropôle Est :
Dr VUITTON Lucine

Tous les auteurs :
Amiot A, Bourrier A, Gornet JM, Dewit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Gagnière C, Buisson A, Nachury M, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Seksik P,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36601289

Résumé

Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown.

Mots clés

COVID-19, Novel coronavirus disease, CRP, C-reactive protein, Crohn's disease, Healthcare worker, IBD, inflammatory bowel disease, Inflammatory bowel disease, SARS-CoV-2, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, TNF, tumor necrosis factor-alpha, UC, ulcerative colitis, Ulcerative colitis

Référence

Infect Prev Pract. 2022 12 30;:100267